Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sweden stimulates biotech start-ups:

This article was originally published in Clinica

Executive Summary

The Karolinska Institute and the Swedish insurance company, SPP, have established a new venture capital fund to invest in R&D projects in the medical, biotechnology and medical technology fields. The Karolinska Investment Fund, of around SKr500 million ($61 million), is one of the first in Sweden to involve an academic institute linking up with an investment group. The fund will invest primarily in research projects at the Karolinska Institute and other medical institutions, universities and colleges in Sweden, thereby providing support for commercialisation of such projects. It is not restricted to investing in the institute or in Sweden, and although its main focus is on early-stage research, it may consider investing in more advanced projects and companies.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079825

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel